Zelestra supports the decarbonization of the pharmaceutical sector by signing a long-term energy supply agreement with Energize

Zelestra, a global, multi-technology, customer-focused renewable energy company, has signed a power purchase agreement (PPA) with Energize in Spain for a capacity of around 161.4 MWdc. Energize is a collaborative programme between 24 global pharmaceutical companies designed to increase access to renewable electricity across the industry supply chain. This landmark agreement is the first Energize cohort purchasing renewable energy together including three Energize sponsors, Takeda Pharmaceuticals International AG, Teva Pharmaceutical Industries Ltd., and UCB Pharma SA and four industry suppliers, Avantor, Organon LLC, Perrigo Pharma International D.A.C. and West Pharmaceutical Services Inc.

This strategic agreement secures the supply of renewable energy for the operations of these pharmaceutical companies and their suppliers for 10 years, marking a significant milestone in their efforts to achieve their collective sustainability and decarbonization goals.

In line with Zelestra’s commitment to support its customers in decarbonizing their operations, the PPA ensures that the pharmaceutical companies purchase approximately 305 GWh of electricity annually.

Ivan Nieto, Chief Commercial Officer of Zelestra, commented: “This agreement marks a significant step towards energy sustainability in the pharmaceutical sector. We are proud to collaborate with these leading companies to provide them with a reliable source of renewable energy, supporting their efforts to meet their environmental goals”.

With this agreement, Zelestra expands its presence in Spain, a key growth market for the company.